Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

1.0K
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
1.0K
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

363
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
363
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
Clinical Trials01:16

Clinical Trials

8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

996
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
996

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Preoperative risk factors for postoperative pneumonia in patients with esophageal cancer: A systematic review and meta-analysis.

Surgery today·2026
Same author

Preoperative risk factors for postoperative pneumonia in patients with esophageal cancer: A systematic review and meta-analysis.

Surgery today·2026
Same author

Evaluation of Participant Characteristics and Short-Term Outcomes in a Community-Based Hypertension Awareness Event in Japan.

International heart journal·2026
Same author

Exercise-nutrition prehabilitation attenuates lean body mass loss before gastrectomy: a randomized controlled trial.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2026
Same author

Bilateral internal carotid artery dissection in a specific unbalanced diet: A case report.

SAGE open medical case reports·2026
Same author

Brain biopsy and metagenomic sequencing enhance aetiological diagnosis of encephalitis.

Brain communications·2025

Related Experiment Video

Updated: May 1, 2026

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

20.2K

[Knowledge-based pharmcodynamics biomarkers implementation using commercially available databases in early-stage

Nobuharu Goto1, Masayuki Suzuki

  • 1Clinical Pharmacology Department, Data Science Center, Development Division, Mitsubishi Tanabe Pharma Corporation.

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|April 4, 2014
PubMed
Summary

This study focuses on implementing pharmacodynamic (PD) biomarkers in drug development. It emphasizes early validation and cross-disciplinary communication for successful clinical trials and regulatory approval.

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.6K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.8K

Related Experiment Videos

Last Updated: May 1, 2026

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

20.2K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.6K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.8K

Area of Science:

  • Biomarker Discovery and Development
  • Translational Medicine
  • Pharmacology

Context:

  • Clinical drug development relies on understanding molecular disease networks for risk, pathogenesis, and prognosis.
  • Pharmacodynamic (PD) biomarkers are crucial for early GO/NO GO decisions in drug development.
  • Reliable biomarker method validation, including analytical and sample handling performance, is essential for successful implementation.

Purpose:

  • To outline a knowledge-based approach for selecting pharmacodynamic biomarkers.
  • To detail a fit-for-purpose strategy for biomarker method validation.
  • To highlight the importance of interdisciplinary communication in biomarker implementation.

Summary:

  • The study discusses the critical role of pharmacodynamic biomarkers in drug development, from molecular understanding to clinical endpoints.
  • It emphasizes the necessity of early, fit-for-purpose validation of biomarker assays and robust communication among diverse scientific teams.
  • A knowledge-based biomarker selection method using commercial databases and a fit-for-purpose validation policy are presented.

Impact:

  • Facilitates informed GO/NO GO decisions in early drug development stages.
  • Ensures trouble-free biomarker implementation through validated methods and clear strategies.
  • Aims to improve the success rate of drug regulatory approval by optimizing biomarker utilization.